The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB
Aim: To analyze the safety of immune checkpoint inhibitors in primary liver cancer patients and to identify the risk factors for immune-related adverse events (irAEs).Methods: The study enrolled 106 patients with primary liver cancer, including 81 with hepatocellular carcinoma and 25 with intrahepat...
Saved in:
Main Authors: | Shike Lou (Author), Zhujun Cao (Author), Wanqing Chi (Author), Xiaoyin Wang (Author), Mingyang Feng (Author), Lanyi Lin (Author), Yezhou Ding (Author), Kehui Liu (Author), Lihong Qu (Author), Gangde Zhao (Author), Shisan Bao (Author), Hui Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy
by: Shike Lou, et al.
Published: (2024) -
Nucleos(T)ide Analogue Treatment Has a More Pronounced Impact on Immune Repertoires of CHB Patients Compared to HCC Patients
by: Shen G, et al.
Published: (2024) -
MB ChB fifth-year student response to e-learning in orthopaedic surgery during COVID-19
by: H Gamieldien, et al.
Published: (2023) -
The main concern of burn survivors in Iran
by: Vahid Zamanzadeh, et al.
Published: (2016) -
The impact of social distancing measures (quarantine) policy on tertiary education and medical consultations in China during the COVID-19 pandemic
by: Zhuoer Wang, et al.
Published: (2024)